Briefing
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Early personalized ctDNA study in gynecologic cancers showing that serial ctDNA dynamically predicted treatment response and survival.
- Design: Evidence level 3
- Assay: Not named in the abstract